Company Overview of Opsona Therapeutics Limited
Opsona Therapeutics Limited operates as a clinical stage biopharmaceutical company. The company primarily focuses on developing drugs for the treatment of autoimmune/inflammatory diseases and inflammatory diseases, transplant rejection, cancer, diabetes, Alzheimer's disease, and atherosclerosis. Its portfolio includes OPN-305, a monoclonal/humanized antibody that reduces pro-inflammatory cytokine production associated with heart and kidney diseases, as well as capable of dampening down the body’s immune response to a donated kidney. The company’s development portfolio includes IL-1ß inhibitors. Opsona Therapeutics Limited was founded in 2004 and is based in Dublin, Ireland.
Founded in 2004
353 1 677 0223
353 1 677 8949
Key Executives for Opsona Therapeutics Limited
Opsona Therapeutics Limited Key Developments
Similar Private Companies By Industry
|Genable Technologies Ltd.||Europe|
|Premier Biomaterials Ltd.||Europe|
|SurgaColl Technologies Ltd||Europe|
|Elan Capital Corp. Ltd.||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Opsona Therapeutics Limited, please visit www.opsona.com. Company data is provided by Capital IQ. Please use this form to report any data issues.